SAN.PA : Summary for SANOFI - Yahoo Finance

U.S. Markets open in 3 hrs 41 mins

Sanofi (SAN.PA)


Paris - Paris Delayed Price. Currency in EUR
Add to watchlist
76.50+0.95 (+1.26%)
As of 5:34 AM EST. Market open.
People also watch:
FP.PABN.PACS.PAOR.PAAI.PA
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close75.55
Open76.14
Bid71.12 x 1000
Ask71.74 x 44000
Day's Range76.04 - 76.75
52 Week Range62.50 - 80.90
Volume994,616
Avg. Volume2,810,641
Market Cap96.9B
BetaN/A
PE Ratio (TTM)23.47
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Sanofi SA (ADR) (SNY) Could Challenge Johnson & Johnson (JNJ) Bid For Actelion Ltd (ALIOF)
    Insider Monkey18 hours ago

    Sanofi SA (ADR) (SNY) Could Challenge Johnson & Johnson (JNJ) Bid For Actelion Ltd (ALIOF)

    Sanofi SA (ADR) (NYSE:SNY) could spark a fierce bidding war for Actelion Ltd (OTCMKTS:ALIOF). Johnson & Johnson (NYSE:JNJ) has already entered talks with Actelion after it sweetened its takeover offer for the company to more than $250 a share to value the Swiss biotechnology firm above $27 billion. But it has emerged that Sanofi is […]

  • The Wall Street Journal18 hours ago

    Big Pharma, Short on Blockbusters, Outsources the Science

    Drug giant Sanofi has formed an unorthodox partnership with a Harvard professor to seek new drugs in areas that have baffled scientists, one of a number of initiatives by Big Pharma to tap outside expertise. ...

  • Bloomberg18 hours ago

    Sanofi Said to Weigh Actelion Bid Challenging J&J

    Sanofi is reported to be considering a bid to challenge Johnson & Johnson's move to acquire Actelion Inc. Bloomberg's Ed Hammond has the details on "Bloomberg Markets." (Source: Bloomberg)